Plain-English translation of NCT06202248 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called DaRT (Diffusing Alpha Emitters Radiation Therapy) seeds for men whose prostate cancer has come back in the same area after previous treatment. The treatment involves placing tiny radioactive seeds directly into the tumor to kill cancer cells. Researchers want to see if this approach is safe and works well for patients with locally recurrent prostate cancer.
Men whose prostate cancer returns in the same location after initial treatment have limited options. This trial exists to see whether implanting radioactive seeds directly into the tumor could be a effective new way to treat these recurrent cancers while potentially causing fewer side effects than other radiation approaches.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo a surgical procedure under anesthesia where doctors use imaging to guide the placement of radioactive seeds directly into your tumor. The seeds are tiny stainless steel tubes that emit radiation to kill cancer cells. You would then be monitored with follow-up imaging and quality-of-life assessments to see how well the treatment works and how you're doing.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Israel